Tonga Healthcare Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tonga Healthcare Daily.

Press releases published on July 30, 2026

7 hours ago

Lexicon Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 6, 2026

Indeterminate GlobeNewswire

7 hours ago

Lite Strategy Repurchases 13% of Outstanding Shares Since December, Increasing Litecoin Backing Per Share

Indeterminate GlobeNewswire

7 hours ago

Cingulate Announces Publication of Phase 3 ADHD Trial Results in Journal of Child and Adolescent Psychopharmacology

Indeterminate GlobeNewswire

7 hours ago

Disc Medicine Reports Second Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

7 hours ago

Newly FDA-Approved REVTORPYK™ (gedatolisib) Included in the National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines for HR+/HER2- Locally Advanced or Metastatic Breast Cancer

Indeterminate GlobeNewswire

7 hours ago

NewGen Provides Update on K25.ai Investment and Strengthened Financial Position

Indeterminate GlobeNewswire

7 hours ago

Clearmind Announces Positive Safety Findings for CMND 100, Demonstrating Consistent Tolerability Throughout Full Dose Escalation in Part A of its FDA-Regulated Clinical Trial

Indeterminate GlobeNewswire

7 hours ago

NurExone Launches Bioprocess Optimization Initiative to Support Commercial and Clinical Readiness

Indeterminate GlobeNewswire

7 hours ago

Cellectar Biosciences to Report Second Quarter Financial Results and Host a Conference Call on Thursday, August 13, 2026

Indeterminate GlobeNewswire

7 hours ago

CytomX Therapeutics to Report Second Quarter 2026 Financial Results on August 6, 2026

Indeterminate GlobeNewswire

7 hours ago

PolyPid to Report Second Quarter 2026 Financial Results and Operational Highlights on August 12, 2026

Indeterminate GlobeNewswire

7 hours ago

Intellia Therapeutics to Hold Conference Call on August 6 to Discuss Second Quarter 2026 Financial Results and Business Updates

Indeterminate GlobeNewswire

7 hours ago

Iovance Biotherapeutics to Report Second Quarter 2026 Financial Results and Corporate Updates on Thursday, August 6, 2026

Indeterminate GlobeNewswire

7 hours ago

Vaxart to Host Stockholder Fireside Chat on August 7 at 4:30 p.m. ET

Indeterminate GlobeNewswire

7 hours ago

Aligos Therapeutics to Announce 2nd Quarter 2026 Financial Results on August 6, 2026

Indeterminate GlobeNewswire

7 hours ago

Nuwellis Announces Acceptance by Frontiers in Pediatrics of New Single-Center Retrospective Study Supporting Alternative Anticoagulation Strategy for Aquadex Ultrafiltration Therapy

Indeterminate GlobeNewswire

7 hours ago

Aprea Therapeutics Provides ACESOT-1051 Program Update for WEE1 Inhibitor APR-1051: Accelerating and Expanding Enrollment. Clinical Data Presentation Planned for Q4 2026

Indeterminate GlobeNewswire

7 hours ago

Verrica Pharmaceuticals to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 6, 2026

Indeterminate GlobeNewswire

7 hours ago

MIRA Pharmaceuticals Progresses MIRA-55 and SKNY-1 Toward IND-Enabling Studies

Indeterminate GlobeNewswire

7 hours ago

Anavex Life Sciences Reports Preliminary Second Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire